
Alpha Profiles · Company Profile
CervoMed Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/cervomed-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: CRVO
- Verification
- Partially verified
- Last reviewed
- 2026-10-06T04:47:21.111185+00:00
Overview
Alpha's canonical identity and public leadership record for CervoMed Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
6 public records- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Executive Vice President, Clinical Development
- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Executive Vice President, Technical Operations
- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Executive Vice President, Regulatory and Government Affairs and Program Management
- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Chief Commercial and Business Officer
- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Chief Financial Officer, General Counsel, Corporate Secretary
- State
- confirmed
- Effective
- From Apr 30, 2026
- Confidence
- 94%
- Evidence
- CRVO DEF 14A executive officersApr 30, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 6, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
8 public records- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- CervoMed Inc. DEF 14A 2025-04-29Apr 29, 2025
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Jeff Poulton
- Members
- Jeff Poulton (Chair); Frank Zavrl
Compensation
- Chair
- Frank Zavrl
- Members
- Frank Zavrl (Chair); Jeff Poulton
Nominating and Governance
- Chair
- Not stated
- Members
- Frank Zavrl
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-06T04:47:21.111185+00:00
